⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8312656 | 0.72 | — | — | |
| SCHEMBL1630360 | 0.50 | — | — | |
| Cynooxide Anion SCHEMBL57006 | 0.43 | — | — | |
| SCHEMBL5223367 | 0.43 | — | — | |
| SCHEMBL90230 | 0.43 | — | — | |
| SCHEMBL375371 | 0.43 | — | — | |
| SCHEMBL12378050 | 0.43 | — | — | |
| Methyldiazonium SCHEMBL8788439 | 0.43 | — | — | |
| SCHEMBL7759796 | 0.43 | — | — | |
| SCHEMBL4249416 | 0.43 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 32 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10634094-B2 | Methods, systems and apparatuses for combustible lead for high triple point propellants | THE BOEING COMPANY (US) | 2020-04-28 | — | — | US | claimed |
| US-10113997-B2 | Methods for gas leak detection and localization in populated areas using two or more tracer measurements | PICARRO, INC. (US) | 2018-10-30 | — | — | US | claimed |
| US-20170342943-A1 | METHODS, SYSTEMS AND APPARATUSES FOR COMBUSTIBLE LEAD FOR HIGH TRIPLE POINT PROPELLANTS | THE BOEING COMPANY | 2017-11-30 | — | — | US | claimed |
| US-20160216172-A1 | Methods for gas leak detection and localization in populated areas using two or more tracer measurements | PICARRO, INC. | 2016-07-28 | — | — | US | claimed |
| EP-2771023-A1 | ORAL FORMULATIONS MIMETIC OF ROUX-EN-Y GASTRIC BYPASS ACTIONS ON THE ILEAL BRAKE; COMPOSITIONS, METHODS OF TREATMENT, DIAGNOSTICS AND SYSTEMS FOR TREATMENT OF METABOLIC SYNDROME MANIFESTATIONS INCLUDING INSULIN RESISTANCE, FATTY LIVER DISEASE, HYPERLIPIDEMIA, AND T2D | Fayad, Joseph M. (US) | 2014-09-03 | — | — | EP | claimed |
| WO-2013063527-A1 | ORAL FORMULATIONS MIMETIC OF ROUX-EN-Y GASTRIC BYPASS ACTIONS ON THE ILEAL BRAKE; COMPOSITIONS, METHODS OF TREATMENT, DIAGNOSTICS AND SYSTEMS FOR TREATMENT OF METABOLIC SYNDROME MANIFESTATIONS INCLUDING INSULIN RESISTANCE, FATTY LIVER DISEASE, HYPERLIPIDEMIA, AND T2D | FAYAD JOSEPH M (US) | 2013-05-02 | — | — | WO | claimed |
| US-20110097807-A1 | METHOD AND SYSTEM TO PROVIDE PERSONALIZED PHARMACEUTICAL COMPOSITIONS AND DOSAGES | JEROME SCHENTAG & THERABRAKE, INC. | 2011-04-28 | — | — | US | claimed |
| US-10634094-B2 | Methods, systems and apparatuses for combustible lead for high triple point propellants | THE BOEING COMPANY (US) | 2020-04-28 | — | — | US | disclosed |
| CN-110638783-A | Oral formulation of Roux-en-Y gastric bypass on ileal brake | 约瑟夫.M.费亚德 | 2020-01-03 | — | — | CN | disclosed |
| US-20190298804-A1 | ACTIVATION OF THE ENDOGENOUS ILEAL BRAKE HORMONE PATHWAY FOR ORGAN REGENERATION AND RELATED COMPOSITIONS, METHODS OF TREATMENT, DIAGNOSTICS, AND REGULATORY SYSTEMS | VOLANT HOLDINGS GMBH (CH) | 2019-10-03 | — | — | US | disclosed |
| US-20190262367-A1 | ORAL FORMULATIONS MIMETIC OF ROUX-EN-Y GASTRIC BYPASS ACTIONS ON THE ILEAL BRAKE; COMPOSITIONS, METHODS OF TREATMENT, DIAGNOSTICS AND SYSTEMS FOR TREATMENT OF METABOLIC SYNDROME MANIFESTATIONS INCLUDING INSULIN RESISTANCE, FATTY LIVER DISEASE, HYPERLIPIDEMIA, AND TYPE 2 DIABETES | VOLANT HOLDINGS GMBH (CH) | 2019-08-29 | — | — | US | disclosed |
| US-20170342943-A1 | METHODS, SYSTEMS AND APPARATUSES FOR COMBUSTIBLE LEAD FOR HIGH TRIPLE POINT PROPELLANTS | THE BOEING COMPANY | 2017-11-30 | — | — | US | disclosed |
| US-20170173060-A1 | ACTIVATION OF THE ENDOGENOUS ILEAL BRAKE HORMONE PATHWAY FOR ORGAN REGENERATION AND RELATED COMPOSITIONS, METHODS OF TREATMENT, DIAGNOSTICS, AND REGULATORY SYSTEMS | VOLANT HOLDINGS GMBH (CH) | 2017-06-22 | — | — | US | disclosed |
| EP-2771023-A1 | ORAL FORMULATIONS MIMETIC OF ROUX-EN-Y GASTRIC BYPASS ACTIONS ON THE ILEAL BRAKE; COMPOSITIONS, METHODS OF TREATMENT, DIAGNOSTICS AND SYSTEMS FOR TREATMENT OF METABOLIC SYNDROME MANIFESTATIONS INCLUDING INSULIN RESISTANCE, FATTY LIVER DISEASE, HYPERLIPIDEMIA, AND T2D | Fayad, Joseph M. (US) | 2014-09-03 | — | — | EP | disclosed |
| WO-2014110090-A1 | ACTIVATION OF THE ENDOGENOUS ILEAL BRAKE HORMONE PATHWAY FOR ORGAN REGENERATION AND RELATED COMPOSITIONS, METHODS OF TREATMENT, DIAGNOSTICS, AND REGULATORY SYSTEMS | SCHENTAG JEROME (US) | 2014-07-17 | — | — | WO | disclosed |
| US-20140037739-A1 | Method and System to Provide Personalized Pharmaceutical Compositions and Dosages | THERASYN SENSORS, INC. (US) | 2014-02-06 | — | — | US | disclosed |
| US-20130273154-A1 | Oral formulations Mimetic of Roux-en-Y gastric bypass actions on the ileal brake; Compositions, Methods of Treatment, Diagnostics and Systems for treatment of metabolic syndrome manifestations including insulin resistance, fatty liver disease, hpperlipidemia, and type 2 diabetes | APHAIA IP AG (CH) | 2013-10-17 | — | — | US | disclosed |
| WO-2013063527-A1 | ORAL FORMULATIONS MIMETIC OF ROUX-EN-Y GASTRIC BYPASS ACTIONS ON THE ILEAL BRAKE; COMPOSITIONS, METHODS OF TREATMENT, DIAGNOSTICS AND SYSTEMS FOR TREATMENT OF METABOLIC SYNDROME MANIFESTATIONS INCLUDING INSULIN RESISTANCE, FATTY LIVER DISEASE, HYPERLIPIDEMIA, AND T2D | FAYAD JOSEPH M (US) | 2013-05-02 | — | — | WO | disclosed |
| US-8367418-B2 | Method and system to provide personalized pharmaceutical compositions and dosages | THERASYN SENSORS, INC. (US) | 2013-02-05 | — | — | US | disclosed |
| US-20110097807-A1 | METHOD AND SYSTEM TO PROVIDE PERSONALIZED PHARMACEUTICAL COMPOSITIONS AND DOSAGES | JEROME SCHENTAG & THERABRAKE, INC. | 2011-04-28 | — | — | US | disclosed |